Search
for
Sort by
Research 91–120 of 1000+
- Protein Kinase C as a Therapeutic Target
- Dutasteride
- The Rationale for Inhibiting 5α-Reductase Isoenzymes in the Prevention and Treatment of Prostate Cancer
- Chapter 17. Selective androgen receptor modulators (SARMs)
- Finasteride-its impact on sexual function and prostate cancer
- 5α-Reductase isozymes and aromatase mRNA levels in plucked hair from young women with female pattern hair loss
- 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- 5α-Reductase Isoenzymes: From Neurosteroid Biosynthesis to Neuropsychiatric Outcomes
- Chemopr�vention des Prostatakarzinoms
- Dihydrotestosterone and 5α-Reductase
- Identification of a preferred substrate peptide for transglutaminase 3 and detection of <i>in situ</i> activity in skin and hair follicles
- In silico structural prediction of human steroid 5α-reductase type II
- Is Dutasteride a Therapeutic Alternative for Amyotrophic Lateral Sclerosis?
- Novel Synthetic Steroid Derivatives: Target Prediction and Biological Evaluation of Antiandrogenic Activity
- Generation of comparative pharmacophoric model for steroidal 5α-reductase I and II inhibitors: A 3D-QSAR study on 6-azasteroids
- Preventive and Therapeutic Efficacy of Finasteride and Dutasteride in TRAMP Mice
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
- Risks and side effects in the medical management of benign prostatic hyperplasia
- Androgen biosynthetic pathways in the human prostate
- Intracrine and Myotrophic Roles of 5α-Reductase and Androgens
- Guava (Psidium guajava L.) Leaf Extract as Bioactive Substances for Anti-Androgen and Antioxidant Activities
- Activity of steroid 4 and derivatives 4a–4f as inhibitors of the enzyme 5α-reductase 1
- Is There an Association between 5a Reductase Inhibitors and Metabolic Syndrome? A Narrative Review of the Literature
- May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications?
- Benign Prostatic Hyperplasia and Sexual Dysfunction: Review of the Impact of New Medical and Surgical Therapies on Sexual Health
- An overview on 5α-reductase inhibitors
- Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride
- Protective role of agomelatine via modulation of TLR4/NF-κB: NLRP3/IL-1β signaling pathways in testosterone-induced benign prostatic hyperplasia in rats
- Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review